Status:

TERMINATED

Visual Function Tests in Age-related Macular Degeneration

Lead Sponsor:

ORA, Inc.

Conditions:

Age Related Macular Degeneration

Eligibility:

All Genders

60-99 years

Brief Summary

The goal of this study is to assess a battery of visual function tests in subjects with non-exudative age-related macular degeneration

Detailed Description

Age-related macular degeneration (AMD) is one of the leading causes of visual impairment among elderly populations in developed countries. Majority of AMD patients (80%) suffer from the dry or non-exu...

Eligibility Criteria

Inclusion

  • All Subjects Must:
  • Be 60 years of age or older;
  • Provide written informed consent;
  • Be willing and able to follow all instructions and attend the study visits;
  • Must be able to perform all study procedures;
  • Normal Subjects:
  • Have BCVA of 20/25 or better in the study eye;
  • Have no history or clinical evidence of AMD, retinal diseases or any other ocular pathologies in either eye;
  • AMD Subjects:
  • Have BCVA of 20/40 or better in the study eye;
  • Have a clinical diagnosis of non-exudative AMD in the study eye;

Exclusion

  • All subjects must not have any of the below criteria
  • <!-- -->
  • Have a diagnosis of wet AMD in the study eye;
  • Have any other hereditary or acquired retinal diseases in either eye ;
  • Have glaucoma or other optic nerve diseases in either eye;
  • Have corneal or other anterior segment diseases in either eye;
  • Have significant cataract in the study eye;
  • Have a history of ocular trauma or ocular surgery (other than cataract removal) in the study eye;
  • Have a history of uncontrolled systemic disease (e.g. poorly controlled hypertension or poorly controlled diabetes);
  • Have a history of seizures;
  • On psychotropic medications;
  • Any other symptoms or conditions that could, in the opinion of the investigator, interfere with study procedures.

Key Trial Info

Start Date :

September 21 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03275753

Start Date

September 21 2017

End Date

December 31 2022

Last Update

April 25 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Andover Eye Associates

Andover, Massachusetts, United States, 01810